trending Market Intelligence /marketintelligence/en/news-insights/trending/Bbp8RPksAQBLquNIoZGIZQ2 content esgSubNav
In This List

Oncobiologics gets Nasdaq noncompliance notice

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Oncobiologics gets Nasdaq noncompliance notice

Oncobiologics Inc. received a noncompliance notice from Nasdaq Global Market for failing to hold its annual meeting within 12 months of its fiscal year end.

The company has 45 calendar days from the date of notification to submit a plan to regain compliance.

On Sept. 29 Oncobiologics filed a statement with the SEC for an annual meeting on Oct. 26.

The notice has no immediate effect on the listing of the company's common stock.